1. Home
  2. NA vs ZURA Comparison

NA vs ZURA Comparison

Compare NA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NA
  • ZURA
  • Stock Information
  • Founded
  • NA 2019
  • ZURA 2022
  • Country
  • NA China
  • ZURA United States
  • Employees
  • NA N/A
  • ZURA N/A
  • Industry
  • NA Semiconductors
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NA Technology
  • ZURA Health Care
  • Exchange
  • NA Nasdaq
  • ZURA Nasdaq
  • Market Cap
  • NA 77.6M
  • ZURA 69.9M
  • IPO Year
  • NA 2022
  • ZURA N/A
  • Fundamental
  • Price
  • NA $7.87
  • ZURA $1.37
  • Analyst Decision
  • NA
  • ZURA Buy
  • Analyst Count
  • NA 0
  • ZURA 7
  • Target Price
  • NA N/A
  • ZURA $14.33
  • AVG Volume (30 Days)
  • NA 1.3M
  • ZURA 682.4K
  • Earning Date
  • NA 03-25-2025
  • ZURA 08-08-2025
  • Dividend Yield
  • NA N/A
  • ZURA N/A
  • EPS Growth
  • NA N/A
  • ZURA N/A
  • EPS
  • NA N/A
  • ZURA N/A
  • Revenue
  • NA $5,561,770.00
  • ZURA N/A
  • Revenue This Year
  • NA N/A
  • ZURA N/A
  • Revenue Next Year
  • NA N/A
  • ZURA N/A
  • P/E Ratio
  • NA N/A
  • ZURA N/A
  • Revenue Growth
  • NA N/A
  • ZURA N/A
  • 52 Week Low
  • NA $2.75
  • ZURA $0.97
  • 52 Week High
  • NA $31.48
  • ZURA $5.07
  • Technical
  • Relative Strength Index (RSI)
  • NA 45.75
  • ZURA 63.32
  • Support Level
  • NA $7.63
  • ZURA $1.00
  • Resistance Level
  • NA $8.90
  • ZURA $1.22
  • Average True Range (ATR)
  • NA 2.94
  • ZURA 0.09
  • MACD
  • NA -0.62
  • ZURA 0.02
  • Stochastic Oscillator
  • NA 1.01
  • ZURA 95.45

About NA Nano Labs Ltd

Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: